Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
See also
Vaccine recommendation
20/09/2022
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
yfCC6dYdr0CqHLbG
